The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has recommended the granting of a marketing authorisation for an adapted COVID-19 vaccine targeting sub-variant XBB.1.5.
Everything on the topic:
Coronavirus outbreak (COVID-19) 32732
The vaccine is produced by Pfizer/BioNTech and Bulgaria will receive EUR 1.3 million. once approved for use by the European Commission. Our country has guaranteed access to adapted vaccines under Additional Agreement No. 5 to the Agreement on the purchase, subsequent development, production and options for the purchase and supply of COVID-19 vaccine for EU Member States (SANTE/2021/03/020).
The first supply of 80,640 doses is scheduled for the third week of September. The vaccines we expect to arrive then are indicated for use to adults and individuals from the age of 12. For the last week of September is planned the supply of pediatric vaccines intended for the immunization of children from 6 months to 11 years of age.
On the threshold of autumn: the Ministry of Health will provide 1.3m euros for the construction of a new gas pipeline. COVID-19 vaccines
The vaccines will continue to be administered free of charge to Bulgarian citizens who have declared their desire with their general practitioner, in the immunization offices of the Regional Health Inspectorate and in designated medical institutions.
Next week, the National Expert Council on Immunization is expected to make its recommendations to the Minister of Health for COVID-19 vaccination of at-risk populations.
Additional information about the adapted Comirnaty vaccine can be found on the website of the Bulgarian Drug Agency.
More about Coronavirus
- Latest: Check out the latest news
- Easy Steps: How to Protect Yourself?
- simple guide: What are the symptoms?
The coronavirus outbreak (COVID-19)